International Journal of Cancer Q1 Unclaimed

Wiley-Liss Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 225. Journal with a Single blind Peer Review review system, and It has a price of 3650 €. The scope of the journal is focused on Cancer, Oncology, Cancer Epidemiology, Cancer Genetics, Tumor. It has an SJR impact factor of 2,154 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3650 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

International Journal of Cancer

2,154

SJR Impact factor

225

H Index

785

Total Docs (Last Year)

1754

Total Docs (3 years)

32135

Total Refs

8698

Total Cites (3 years)

1626

Citable Docs (3 years)

5,23

Cites/Doc (2 years)

40,94

Ref/Doc

Aims and Scope


Cancer Oncology Cancer Epidemiology Cancer Genetics Tumor


Best articles

A survey of the human T-cell lymphotropic virus type I (HTLV-I) in South-Western Colombia

View more

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

View more

Acne and risk of prostate cancer

View more

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope

View more

Analysis of T-cell-receptor ?-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas

View more

Analysis ofHIC-1 methylation and transcription in human ependymomas

View more

Assessment of health status and health-related quality of life in survivors of Hodgkin's disease in childhood

View more

Association between war and cervical cancer among Vietnamese women

View more

Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines

View more

Biologic properties of a Ch2 domain-deleted recombinant immunoglobulin

View more

Breast cancer survival in England, Norway and Sweden: a population-based comparison

View more

Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013

View more
SHOW MORE ARTICLES

CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients

View more

Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors

View more

Comprehensive analysis of the contribution of germlineMYH variation to early-onset colorectal cancer

View more

Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: A population-based study

View more

Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction

View more

Definition of candidate low risk APC alleles in a Swedish population

View more

Deregulation of beta-catenin signal byHelicobacter pylori CagA requires the CagA-multimerization sequence

View more

Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America

View more

Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population-based case-control study in Sweden

View more

Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPAR? expression and alteration of lipid composition

View more

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma

View more

Differential MHC class II component expression in HPV-positive cervical cancer cells: Implication for immune surveillance

View more

Comments

No comments ... Be the first to comment!